A detailed history of Orbimed Advisors LLC transactions in Ab Cellera Biologics Inc. stock. As of the latest transaction made, Orbimed Advisors LLC holds 4,180,768 shares of ABCL stock, worth $12.2 Million. This represents 0.26% of its overall portfolio holdings.

Number of Shares
4,180,768
Previous 4,180,768 -0.0%
Holding current value
$12.2 Million
Previous $12.4 Million 12.5%
% of portfolio
0.26%
Previous 0.3%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021

SELL
$14.85 - $21.34 $30.3 Million - $43.6 Million
-2,042,251 Reduced 32.82%
4,180,768 $83.8 Million
Q2 2021

Aug 16, 2021

SELL
$20.19 - $34.17 $39.9 Million - $67.6 Million
-1,977,749 Reduced 24.12%
6,223,019 $137 Million
Q1 2021

May 17, 2021

SELL
$23.29 - $53.2 $4.66 Million - $10.6 Million
-200,000 Reduced 2.38%
8,200,768 $278 Million
Q4 2020

Feb 16, 2021

BUY
$39.0 - $58.9 $328 Million - $495 Million
8,400,768 New
8,400,768 $338 Million

Others Institutions Holding ABCL

About AbCellera Biologics Inc.


  • Ticker ABCL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 285,139,008
  • Market Cap $833M
  • Description
  • AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...
More about ABCL
Track This Portfolio

Track Orbimed Advisors LLC Portfolio

Follow Orbimed Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Orbimed Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Orbimed Advisors LLC with notifications on news.